null - FindTrial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2016-002331-16-FR

Enrollment

506

Registered

2016-10-19

Start date

2016-10-03

Completion date

Unknown

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 19.0 Level: LLT Classification code 10042080 Term: Stomach cancer System Organ Class: 100000004864 MedDRA version: 19.0 Level: LLT Classification code 10042089 Term: Stomach cancer stage IV without metastases System Organ Class: 100000004864 MedDRA version: 19.0 Level: LLT Classification code 10042088 Term: Stomach cancer stage IV with metastases System Organ Class: 100000004864

Interventions

Trade Name: TAXOTERE Pharmaceutical Form: Solution for infusion INN or Proposed INN: DOCETAXEL CAS Number: 114977-28-5 Other descriptive name: ANHYDROUS DOCETAXEL Concentration unit: mg/ml milligram(s

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 206 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 300

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactChef de Projet

Fédération Francophone de Cancérologie Digestive

marie.moreau@u-bourgogne.fr+33380 39 34 04

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026